It looks like this fish oil drug is working wonders for those taking it. (I started on it about two months ago and it cut my tryglicirides by 40% but it’s ultra expensive stuff.
Is this a boon or a bane or just not relevant for our BETOnMACE project that we are expecting to hear more about by July ‘19 (or later)
In the meantime not much to expect, except our long awaited wait for the promised additional funding discussed at the end of January.
Comments? (Up to $19 per share on the Vascepa parent)